• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply
Sort by Relevance
CSV RIS
Search Results [15895 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2019 National Institute for Health and Care Excellence (NICE) Ocrelizumab for treating primary progressive multiple sclerosis. NICE technology appraisal guidance 585
2019 National Institute for Health and Care Excellence (NICE) Lenalidomide plus dexamethasone for multiple myeloma after 1 treatment with bortezomib. NICE technology appraisal guidance 586
2019 National Institute for Health and Care Excellence (NICE) Lenalidomide plus dexamethasone for previously untreated multiple myeloma. NICE technology appraisal guidance 587
2019 National Institute for Health and Care Excellence (NICE) Nusinersen for treating spinal muscular atrophy. NICE technology appraisal guidance 588
2019 National Institute for Health and Care Excellence (NICE) Blinatumomab for treating acute lymphoblastic leukaemia in remission with minimal residual disease activity. NICE technology appraisal guidance 589
2019 National Institute for Health and Care Excellence (NICE) Fluocinolone acetonide intravitreal implant for treating recurrent non-infectious uveitis. NICE technology appraisal guidance 590
2019 National Institute for Health and Care Excellence (NICE) Letermovir for preventing cytomegalovirus disease after a stem cell transplant. NICE technology appraisal guidance 591
2019 National Institute for Health and Care Excellence (NICE) Brentuximab vedotin for untreated advanced Hodgkin lymphoma (terminated appraisal). NICE technology appraisal guidance 594
2019 National Institute for Health and Care Excellence (NICE) Dacomitinib for untreated EGFR mutation-positive non-small-cell lung cancer. NICE technology appraisal guidance 595
2019 National Institute for Health and Care Excellence (NICE) Risankizumab for treating moderate to severe plaque psoriasis. NICE technology appraisal guidance 596
2019 National Institute for Health and Care Excellence (NICE) Olaparib for maintenance treatment of BRCA mutation-positive advanced ovarian, fallopian tube or peritoneal cancer after response to first-line platinum-based chemotherapy. NICE technology appraisal guidance 598
2019 National Institute for Health and Care Excellence (NICE) Sodium zirconium cyclosilicate for treating hyperkalaemia. NICE technology appraisal guidance 599
2019 National Institute for Health and Care Excellence (NICE) Pomalidomide with bortezomib and dexamethasone for treating relapsed or refractory multiple myeloma (terminated appraisal). NICE technology appraisal guidance 602
2019 National Institute for Health and Care Excellence (NICE) Lenalidomide with bortezomib and dexamethasone for untreated multiple myeloma (terminated appraisal). NICE technology appraisal guidance 603
2019 National Institute for Health and Care Excellence (NICE) Idelalisib for treating refractory follicular lymphoma. NICE technology appraisal guidance 604
2019 National Institute for Health and Care Excellence (NICE) Xeomin (botulinum neurotoxin type A) for treating chronic sialorrhoea. NICE technology appraisal guidance 605
2019 National Institute for Health and Care Excellence (NICE) Lanadelumab for preventing recurrent attacks of hereditary angioedema. NICE technology appraisal guidance 606
2019 National Institute for Health and Care Excellence (NICE) Rivaroxaban for preventing atherothrombotic events in people with coronary or peripheral artery disease. NICE technology appraisal guidance 607
2019 National Institute for Health and Care Excellence (NICE) Ibrutinib with rituximab for treating Waldenstrom's macroglobulinaemia (terminated appraisal). NICE technology appraisal guidance 608
2019 National Institute for Health and Care Excellence (NICE) Ramucirumab for treating unresectable hepatocellular carcinoma after sorafenib (terminated appraisal). NICE technology appraisal guidance 609
2019 National Institute for Health and Care Excellence (NICE) Pentosan polysulfate sodium for treating bladder pain syndrome. NICE technology appraisal guidance 610
2019 National Institute for Health and Care Excellence (NICE) Rucaparib for maintenance treatment of relapsed platinum-sensitive ovarian, fallopian tube or peritoneal cancer. NICE technology appraisal guidance 611
2019 National Institute for Health and Care Excellence (NICE) Neratinib for extended adjuvant treatment of hormone receptor-positive, HER2-positive early stage breast cancer after adjuvant trastuzumab. NICE technology appraisal guidance 612
2019 National Institute for Health and Care Excellence (NICE) Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema in phakic eyes after an inadequate response to previous therapy. NICE technology appraisal guidance 613
2019 National Institute for Health and Care Excellence (NICE) Cannabidiol with clobazam for treating seizures associated with Dravet syndrome. NICE technology appraisal guidance 614
2019 National Institute for Health and Care Excellence (NICE) Cannabidiol with clobazam for treating seizures associated with Lennox-Gastaut syndrome. NICE technology appraisal guidance 615
2019 National Institute for Health and Care Excellence (NICE) Cladribine for treating relapsing–remitting multiple sclerosis. NICE technology appraisal guidance 616
2019 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Cleft lip and palate: does using the nasoalveolar molding method before surgery lead to better results?]
2019 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Cancer: can concomitant music therapy contribute to better treatment results?]
2019 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [How do non-drug interventions influence coping with suicidal crises in unipolar depression?]
2019 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Idiopathic scoliosis: is video rasterstereography an adequate replacement for radiography in aftercare?]
2019 National Institute for Health and Care Excellence (NICE) Balloon dilation for chronic eustachian tube dysfunction. NICE interventional procedures guidance 665
2019 National Institute for Health and Care Excellence (NICE) Irreversible electroporation for primary liver cancer. NICE interventional procedures guidance 664
2019 National Institute for Health and Care Excellence (NICE) Midcarpal hemiarthroplasty for wrist arthritis. NICE interventional procedures guidance 663
2019 National Institute for Health and Care Excellence (NICE) High-intensity focused ultrasound for glaucoma. NICE interventional procedures guidance 661
2019 National Institute for Health and Care Excellence (NICE) Bioprosthetic plug insertion for anal fistula. NICE interventional procedures guidance 662
2019 National Institute for Health and Care Excellence (NICE) Implant insertion for prominent ears. NICE interventional procedures guidance 660
2019 National Institute for Health and Care Excellence (NICE) Endovascular insertion of an intrasaccular wire-mesh blood-flow disruption device for intracranial aneurysms. NICE interventional procedures guidance 658
2019 National Institute for Health and Care Excellence (NICE) Low-energy contact X-ray brachytherapy (the Papillon technique) for locally advanced rectal cancer. NICE interventional procedures guidance 659
2019 National Institute for Health and Care Excellence (NICE) Transurethral laser ablation for recurrent non-muscle-invasive bladder cancer. NICE interventional procedures guidance 656
2019 National Institute for Health and Care Excellence (NICE) Ultrasound-guided high-intensity transcutaneous focused ultrasound for symptomatic uterine fibroids. NICE interventional procedures guidance 657
2019 National Institute for Health and Care Excellence (NICE) Cardiac contractility modulation device implantation for heart failure. NICE interventional procedures guidance 655
2019 National Institute for Health and Care Excellence (NICE) Valve-in-valve TAVI for aortic bioprosthetic valve dysfunction. NICE interventional procedures guidance 653
2019 National Institute for Health and Care Excellence (NICE) Reinforcement of a permanent stoma with a synthetic or biological mesh to prevent a parastomal hernia. NICE interventional procedures guidance 654
2019 National Institute for Health and Care Excellence (NICE) Percutaneous insertion of a cerebral protection device to prevent cerebral embolism during TAVI. NICE interventional procedures guidance 650
2019 National Institute for Health and Care Excellence (NICE) Percutaneous mechanical thrombectomy for acute deep vein thrombosis of the leg. NICE interventional procedures guidance 651
2019 National Institute for Health and Care Excellence (NICE) Bronchoscopic thermal vapour ablation for upper-lobe emphysema. NICE interventional procedures guidance 652
2019 National Institute for Health and Care Excellence (NICE) Therapeutic hypothermia for acute ischaemic stroke. NICE interventional procedures guidance 647
2019 National Institute for Health and Care Excellence (NICE) Collagen paste for closing an anal fistula. NICE interventional procedures guidance 648
2019 National Institute for Health and Care Excellence (NICE) Percutaneous mitral valve leaflet repair for mitral regurgitation. NICE interventional procedures guidance 649
2019 National Institute for Health and Care Excellence (NICE) Endoscopic ablation for an anal fistula. NICE interventional procedures guidance 645
2019 National Institute for Health and Care Excellence (NICE) Endoscopic ablation for a pilonidal sinus. NICE interventional procedures guidance 646
2019 National Institute for Health and Care Excellence (NICE) Radially emitting laser fibre treatment of an anal fistula. NICE interventional procedures guidance 644
2019 National Institute for Health and Care Excellence (NICE) High-intensity focused ultrasound for symptomatic benign thyroid nodules. NICE interventional procedures guidance 643
2019 National Institute for Health and Care Excellence (NICE) Barnett Continent Intestinal Reservoir (modified continent ileostomy) to restore continence after colon and rectum removal. NICE interventional procedures guidance 642
2019 National Institute for Health and Care Excellence (NICE) Electrically stimulated intravesical chemotherapy for non-muscle-invasive bladder cancer. NICE interventional procedures guidance 638
2019 National Institute for Health and Care Excellence (NICE) Laparoscopic cerclage for cervical incompetence to prevent late miscarriage or preterm birth. NICE interventional procedures guidance 639
2019 National Institute for Health and Care Excellence (NICE) Percutaneous venoplasty for chronic cerebrospinal venous insufficiency in multiple sclerosis. NICE interventional procedures guidance 640
2019 National Institute for Health and Care Excellence (NICE) Platelet-rich plasma injections for knee osteoarthritis. NICE interventional procedures guidance 637
2019 National Institute for Health and Care Excellence (NICE) Ex-situ machine perfusion for extracorporeal preservation of livers for transplantation. NICE interventional procedures guidance 636
2019 National Institute for Health and Care Excellence (NICE) UrgoStart for treating diabetic foot ulcers and leg ulcers. NICE medical technologies guidance 42
2019 National Institute for Health and Care Excellence (NICE) gammaCore for cluster headache. NICE medical technologies guidance 46
2019 National Institute for Health and Care Excellence (NICE) PICO negative pressure wound dressings for closed surgical incisions. NICE medical technologies guidance 43
2019 National Institute for Health and Care Excellence (NICE) Endocuff Vision for assisting visualisation during colonoscopy. NICE medical technologies guidance 45
2019 National Institute for Health and Care Excellence (NICE) Curos for preventing infections when using needleless connectors. NICE medical technologies guidance 44
2019 National Institute for Health and Care Excellence (NICE) Senza spinal cord stimulation system for delivering HF10 therapy to treat chronic neuropathic pain. NICE medical technologies guidance 41
2019 National Institute for Health and Care Excellence (NICE) Mepilex Border Heel and Sacrum dressings for preventing pressure ulcers. NICE medical technologies guidance 40
2019 National Institute for Health and Care Excellence (NICE) Point-of-care creatinine devices to assess kidney function before CT imaging with intravenous contrast. NICE diagnostics guidance 37
2019 National Institute for Health and Care Excellence (NICE) Rapid tests for group A streptococcal infections in people with a sore throat. NICE diagnostics guidance 38
2019 National Institute for Health and Care Excellence (NICE) Therapeutic monitoring of TNF-alpha inhibitors in rheumatoid arthritis. NICE diagnostics guidance 36
2019 National Institute for Health and Care Excellence (NICE) Lead-I ECG devices for detecting symptomatic atrial fibrillation using single time point testing in primary care. NICE diagnostics guidance 35
2019 Health Information and Quality Authority (HIQA) Clinical and cost-effectiveness of the National Early Warning System (NEWS): a systematic review update. The Irish National Early Warning System (NEWS) National Clinical Guideline No. 1
2019 Health Information and Quality Authority (HIQA) Risk in pregnancy — systematic review of economic literature.
2019 Health Information and Quality Authority (HIQA) Budget impact analysis – stratification of clinical risk in pregnancy
2019 Health Information and Quality Authority (HIQA) Systematic review of nutritional screening tools for adult patients in acute hospital settings. Nutrition screening and use of oral nutrition support for adults in the acute care setting
2018 Haute Autorite de sante (HAS) [Autism spectrum disorder: Warning signs, detection, diagnosis and assessment in children and adolescents]
2018 Medical Services Advisory Committee (MSAC) Computed tomography coronary angiogram - multi-slice computed tomography coronary angiography in the visualisation of coronary arteries
2018 Haute Autorite de sante (HAS) [Treatment of superficial stomach cancer by endoscopic submucosal dissection (ESD)]
2018 NIHR Health Technology Assessment programme UK Lung Cancer Screening Trial (UKLS) - Feasibility study and protocol development
2018 NIHR Health Technology Assessment programme Amaze: a double-blind, multicentre randomised controlled trial to investigate the clinical effectiveness and cost-effectiveness of adding an ablation device-based maze procedure as an adjunct to routine cardiac surgery for patients with pre-existing atrial fibrillation
2018 NIHR Health Technology Assessment programme Strategy of endovascular versus open repair for patients with clinical diagnosis of ruptured abdominal aortic aneurysm: the IMPROVE RCT
2018 NIHR Health Technology Assessment programme PET-PANC: multicentre prospective diagnostic accuracy and health economic analysis study of the impact of combined modality 18fluorine-2-fluoro-2-deoxy-d-glucose positron emission tomography with computed tomography scanning in the diagnosis and management of pancreatic cancer
2018 NIHR Health Technology Assessment programme Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study
2018 NIHR Health Technology Assessment programme Computerised interpretation of the fetal heart rate during labour: a randomised controlled trial (INFANT)
2018 NIHR Health Technology Assessment programme Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT
2018 NIHR Health Technology Assessment programme The West Midlands ActiVe lifestyle and healthy Eating in School children (WAVES) study: a cluster randomised controlled trial testing the clinical effectiveness and cost-effectiveness of a multifaceted obesity prevention intervention programme targeted at children aged 6-7 years
2018 NIHR Health Technology Assessment programme Amisulpride for very late-onset schizophrenia-like psychosis: the ATLAS three-arm RCT
2018 NIHR Health Technology Assessment programme Alternative tumour necrosis factor inhibitors (TNFi) or abatacept or rituximab following failure of initial TNFi in rheumatoid arthritis: the SWITCH RCT
2018 NIHR Health Technology Assessment programme Improving the Quality of Dentistry (IQuaD): A cluster factorial randomised controlled trial comparing the effectiveness and cost-benefit of oral hygiene advice and/or periodontal instrumentation with routine care for the prevention and management of periodontal disease in dentate adults attending dental primary care
2018 NIHR Health Technology Assessment programme Routine low-dose continuous or nocturnal oxygen for people with acute stroke: three-arm Stroke Oxygen Supplementation RCT
2018 NIHR Health Technology Assessment programme AntiEpileptic drug Monitoring in PREgnancy (EMPiRE): a double-blind randomised trial on effectiveness and acceptability of monitoring strategies
2018 NIHR Health Technology Assessment programme MRI versus laparoscopy to diagnose the main causes of chronic pelvic pain in women: a test-accuracy study and economic evaluation
2018 NIHR Health Technology Assessment programme A pedometer-based walking intervention in 45- to 75-year-olds, with and without practice nurse support: the PACE-UP three-arm cluster RCT
2018 NIHR Health Technology Assessment programme Multiparametric MRI to improve detection of prostate cancer compared with transrectal ultrasound-guided prostate biopsy alone: the PROMIS study
2018 NIHR Health Technology Assessment programme Negative-pressure wound therapy versus standard dressings for adults with an open lower limb fracture: the WOLLF RCT
2018 NIHR Health Technology Assessment programme Aerobic and strength training exercise programme for cognitive impairment in people with mild to moderate dementia: the DAPA RCT
2018 NIHR Health Technology Assessment programme A randomised controlled trial and economic evaluation of intraoperative cell salvage during caesarean section in women at risk of haemorrhage: the SALVO (cell SALVage in Obstetrics) trial
2018 NIHR Health Technology Assessment programme Nicotine preloading for smoking cessation: the Preloading RCT
2018 NIHR Health Technology Assessment programme Lamotrigine for people with borderline personality disorder: a RCT
2018 NIHR Health Technology Assessment programme Enteral lactoferrin to prevent infection for very preterm infants: the ELFIN RCT